Why Is Triamcinolone So Hard to Find? [Explained for 2026]

If you or your doctor recently tried to fill a triamcinolone injection prescription and came back empty-handed, you are not alone. Triamcinolone acetonide injectable suspension is in an active, officially declared shortage as of 2026 — and the situation involves nearly every major manufacturer at the same time. Understanding why this is happening can help you plan around it.

Which Forms of Triamcinolone Are Actually Hard to Find?

Not all triamcinolone is equally affected. The shortage is concentrated in the injectable suspension, particularly the 40 mg/mL vials used for intramuscular injections, joint injections, and intralesional procedures. The topical forms — creams, ointments, and lotions — are generally well-stocked at most pharmacies. Over-the-counter Nasacort nasal spray is also widely available on pharmacy shelves.

Here is a quick breakdown of availability by form in 2026:

Injectable 40 mg/mL (Kenalog-40 and generics): Active shortage — multiple manufacturers reporting back orders and allocation

Topical cream and ointment (0.025%, 0.1%, 0.5%): Generally available at most pharmacies

Nasacort nasal spray (OTC): Widely available over the counter, no prescription needed

Dental paste (Oralone): Sporadically available; may require pharmacy ordering

Why Is the Injectable Form in Shortage?

The ASHP (American Society of Health-System Pharmacists) officially tracked this shortage beginning in June 2025. Several compounding factors are driving the crisis:

Manufacturing issues: Several manufacturers have cited requirements for complying with good manufacturing practices (GMP) as a reason for disruptions.

Eugia discontinued: Eugia discontinued triamcinolone acetonide injectable suspension entirely in mid-2025, removing a significant supply source.

Simultaneous multi-manufacturer pressure: Teva, Hikma, Long Grove, Viatris, and Bristol-Myers Squibb (brand Kenalog) have all reported supply constraints at the same time, leaving no single manufacturer able to absorb the shortfall.

Increased demand: Long Grove has cited increased demand as a contributing factor — more patients are receiving joint injections and allergy shots as healthcare backlogs clear.

Who Is Most Affected by the Triamcinolone Shortage?

Patients who receive triamcinolone injections for arthritis, bursitis, tendinitis, or seasonal allergies are the most directly impacted. Because the injectable form cannot simply be swapped for the topical cream in most cases, there is no easy at-home substitute. Clinics and orthopedic practices that routinely stock triamcinolone vials are also struggling to source supplies for in-office use.

Is the Triamcinolone Topical Cream Also Hard to Find?

For most patients prescribed triamcinolone acetonide cream or ointment for skin conditions, availability is generally good. Generic 0.1% cream is manufactured by multiple companies and is stocked at the vast majority of retail pharmacies. That said, specific strengths (like 0.5%) or specialty formulations may occasionally require a call ahead to verify stock. If your pharmacy is out, another nearby pharmacy is usually an option.

What Can Patients Do Right Now?

If you need the injectable form, here are the most practical steps:

Call multiple pharmacies — major chains, independent pharmacies, and compounding pharmacies all source from different distributors. Stock varies widely from one location to the next.

Ask your provider about alternatives such as methylprednisolone acetate (Depo-Medrol) for joint and soft-tissue injections, or betamethasone for certain uses.

Try a pharmacy finder service. medfinder calls pharmacies near you to check which ones have your medication in stock, so you do not have to spend hours on hold.

Consider compounding pharmacies, which can prepare triamcinolone injectable suspension from raw ingredients when commercially manufactured product is unavailable.

When Will the Triamcinolone Injection Shortage Be Resolved?

As of early 2026, Viatris has estimated a product release of late June 2026, and Amneal has product on allocation. Bristol-Myers Squibb (brand Kenalog) is also working to restore supply. However, shortage timelines in the pharmaceutical industry are notoriously unreliable — delays and extensions are common. Checking current ASHP shortage notices for the latest status is recommended.

How medfinder Can Help

Calling dozens of pharmacies by hand is time-consuming and frustrating. medfinder does the calling for you. You provide your medication, dosage, and zip code — and medfinder contacts pharmacies near you to find out which ones can fill your prescription. Results are texted back to you, so you can go directly to the pharmacy that has it in stock. It covers all medications, not just shortage drugs.

Want a deeper dive into the shortage timeline? Read our full Triamcinolone shortage update for 2026 for the latest manufacturer updates and patient-facing guidance.

Also see: Alternatives to Triamcinolone if you can't fill your prescription for a practical comparison of options.